• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺腺瘤和恶性肾上腺结节 CT 生长速度的差异。

Differences in Growth Rate on CT of Adrenal Adenomas and Malignant Adrenal Nodules.

机构信息

Department of Radiology, University of California, Davis Medical Center, 4860 Y St, Ste 3100, Sacramento, CA 95817.

Department of Surgery, University of California, Davis Medical Center, Sacramento, CA.

出版信息

AJR Am J Roentgenol. 2019 Sep;213(3):632-636. doi: 10.2214/AJR.19.21342. Epub 2019 Apr 30.

DOI:10.2214/AJR.19.21342
PMID:31039016
Abstract

The purpose of this study is to determine the differences in growth rate of adrenal adenomas and malignant adrenal nodules. This was a retrospective review of adults with an adrenal nodule seen at two different abdominal or chest CT examinations or PET/CT examinations. Patients in the adenoma group were included if they had a CT, MRI, or pathologic diagnosis of an adrenal adenoma. Patients in the malignant group were included if they had a pathologically proven malignant adrenal nodule. Nodule growth was defined as a change in the largest axial diameter greater than or equal to 3 mm. Growth rate was calculated by dividing the change in the longest axial diameter by the time between the first and last imaging examination. There were 105 adenomas and 26 malignant nodules. Of the 105 adenomas, 34 (32.4%; 95% CI, 23.6-42.2%) grew, three (2.9%; 95% CI, 0.6-8.1%) became smaller, and 68 (64.8%; 95% CI, 54.8-73.8%), were unchanged in size. All 26 (100%; 95% CI, 89.1-100%) malignant nodules grew. The mean (± SD) growth rate of adenomas was 1.0 ± 0.67 mm/year (range, 0.3-2.8 mm/year), compared with 58.4 ± 78.5 mm/year (range, 5.8-395.4 mm/year) for malignant nodules ( < 0.001). A growth rate of 3 mm/year distinguished adenomas from malignant nodules with a sensitivity of 100% (95% CI, 86.8-100%) and a specificity of 100% (95% CI, 96.6-100%). Approximately one-third of radiologically proven adrenal adenomas grew, all of which grew at a rate less than 3 mm/year. All malignant adrenal nodules grew, and all at a rate greater than 5 mm/year.

摘要

本研究旨在确定肾上腺腺瘤和恶性肾上腺结节生长速度的差异。这是一项对在两次不同的腹部或胸部 CT 检查或 PET/CT 检查中发现肾上腺结节的成年人进行的回顾性研究。如果 CT、MRI 或病理诊断为肾上腺腺瘤,则将患者纳入腺瘤组。如果病理证实为恶性肾上腺结节,则将患者纳入恶性组。结节生长定义为最大轴向直径的变化大于或等于 3 毫米。生长速率通过将最长轴向直径的变化除以第一次和最后一次影像学检查之间的时间来计算。共发现 105 个腺瘤和 26 个恶性结节。在 105 个腺瘤中,有 34 个(32.4%;95%CI,23.6-42.2%)生长,3 个(2.9%;95%CI,0.6-8.1%)变小,68 个(64.8%;95%CI,54.8-73.8%)大小不变。所有 26 个(100%;95%CI,89.1-100%)恶性结节均生长。腺瘤的平均(±SD)生长速度为 1.0±0.67mm/年(范围,0.3-2.8mm/年),而恶性结节为 58.4±78.5mm/年(范围,5.8-395.4mm/年)(<0.001)。生长速度为 3mm/年可将腺瘤与恶性结节区分开来,其敏感性为 100%(95%CI,86.8-100%),特异性为 100%(95%CI,96.6-100%)。约三分之一的经影像学证实的肾上腺腺瘤生长,其生长速度均小于 3mm/年。所有恶性肾上腺结节均生长,且生长速度均大于 5mm/年。

相似文献

1
Differences in Growth Rate on CT of Adrenal Adenomas and Malignant Adrenal Nodules.肾上腺腺瘤和恶性肾上腺结节 CT 生长速度的差异。
AJR Am J Roentgenol. 2019 Sep;213(3):632-636. doi: 10.2214/AJR.19.21342. Epub 2019 Apr 30.
2
Dual-energy CT for characterization of adrenal nodules: initial experience.双能 CT 对肾上腺结节的特征分析:初步经验。
AJR Am J Roentgenol. 2010 Jun;194(6):1479-83. doi: 10.2214/AJR.09.3476.
3
Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.应用 CT 直方图分析方法对肾上腺腺瘤与非腺瘤进行鉴别诊断:一项前瞻性研究。
Eur J Radiol. 2010 Mar;73(3):643-51. doi: 10.1016/j.ejrad.2008.12.010. Epub 2009 Jan 22.
4
Interobserver agreement in distinguishing large adrenal adenomas and adrenocortical carcinomas on computed tomography.在计算机断层扫描中区分大肾上腺腺瘤和肾上腺皮质癌的观察者间一致性。
Abdom Radiol (NY). 2018 Nov;43(11):3101-3108. doi: 10.1007/s00261-018-1603-3.
5
Differentiation of adrenal tumors in patients with hepatocellular carcinoma: adrenal adenoma versus metastasis.肝细胞癌患者肾上腺肿瘤的鉴别诊断:肾上腺腺瘤与转移瘤。
Eur J Radiol. 2013 Aug;82(8):1213-8. doi: 10.1016/j.ejrad.2013.02.019. Epub 2013 Mar 9.
6
Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.鉴别肾上腺腺瘤与非腺瘤:未增强及短时间5分钟动态增强CT方案诊断参数的联合应用
Radiology. 2009 Feb;250(2):474-81. doi: 10.1148/radiol.2502080302. Epub 2008 Nov 26.
7
Evaluation of diagnostic accuracy: multidetector CT image noise correction improves specificity of a Gaussian model-based algorithm used for characterization of incidental adrenal nodules.诊断准确性评估:多排 CT 图像噪声校正提高了基于高斯模型的算法在偶然肾上腺结节特征描述中的特异性。
Abdom Radiol (NY). 2019 Mar;44(3):1033-1043. doi: 10.1007/s00261-018-1871-y.
8
The adrenal mass: correlation of histopathology with imaging.肾上腺肿块:组织病理学与影像学的相关性。
Ann Surg Oncol. 2010 Mar;17(3):846-52. doi: 10.1245/s10434-009-0829-2. Epub 2009 Dec 4.
9
Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?纹理分析能否用于在平扫 CT、增强 CT 或同相位及反相位 MRI 上区分良恶性肾上腺结节?
AJR Am J Roentgenol. 2019 Mar;212(3):554-561. doi: 10.2214/AJR.18.20097. Epub 2019 Jan 8.
10
Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.MRI鉴别肾透明细胞癌肾上腺转移瘤与肾上腺腺瘤的效用
AJR Am J Roentgenol. 2017 Sep;209(3):W152-W159. doi: 10.2214/AJR.16.17649. Epub 2017 Jul 25.

引用本文的文献

1
Washed up: the end of an era for adrenal incidentaloma CT.大势已去:肾上腺偶发瘤CT检查时代的终结
Insights Imaging. 2025 Jun 27;16(1):136. doi: 10.1186/s13244-025-02015-4.
2
Adrenalectomy Performed with the Da Vinci Single-Port Robotic System: A Systematic Review and Pooled Analysis.使用达芬奇单孔机器人系统进行肾上腺切除术:系统评价与汇总分析
Cancers (Basel). 2025 Apr 20;17(8):1372. doi: 10.3390/cancers17081372.
3
Using interpretable rule-learning artificial intelligence to optimally differentiate adrenal pheochromocytomas from adenomas with CT radiomics.
利用可解释的规则学习人工智能和CT影像组学对肾上腺嗜铬细胞瘤与腺瘤进行最佳鉴别。
Abdom Radiol (NY). 2025 Mar 26. doi: 10.1007/s00261-025-04893-0.
4
Quantitative imaging biomarkers in the assessment of adrenal nodules.肾上腺结节评估中的定量成像生物标志物
Abdom Radiol (NY). 2025 May;50(5):2169-2180. doi: 10.1007/s00261-024-04671-4. Epub 2024 Nov 13.
5
Development and validation of a model predicting adrenal lipid-poor adenoma based on the minimum attenuation value from non-contrast CT: a dual-center retrospective study.基于非增强 CT 最小衰减值预测无脂性腺瘤的模型的建立和验证:一项双中心回顾性研究。
BMC Med Imaging. 2024 Aug 12;24(1):210. doi: 10.1186/s12880-024-01392-4.
6
Transformation of a Benign Adrenocortical Adenoma to a Metastatic Adrenocortical Carcinoma Is Rare But It Happens.良性肾上腺皮质腺瘤转变为转移性肾上腺皮质癌虽罕见,但确有发生。
JCEM Case Rep. 2024 Jul 30;2(8):luae131. doi: 10.1210/jcemcr/luae131. eCollection 2024 Aug.
7
Non-contrast spectral CT vs chemical-shift MRI in discriminating lipid-poor adrenal lesions.非增强光谱CT与化学位移MRI在鉴别乏脂性肾上腺病变中的应用比较
Eur Radiol. 2025 Jan;35(1):370-380. doi: 10.1007/s00330-024-10929-8. Epub 2024 Jul 10.
8
Adrenal washout CT in patients with no history of cancer: a waste of time?肾上腺洗脱 CT 在无癌症病史患者中的应用:浪费时间吗?
Abdom Radiol (NY). 2024 Sep;49(9):3117-3126. doi: 10.1007/s00261-024-04333-5. Epub 2024 May 21.
9
Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.肝脏 CT 和化学位移 MRI 鉴别乏脂性肾上腺腺瘤与肝细胞癌转移的诊断性能。
Abdom Radiol (NY). 2024 May;49(5):1626-1637. doi: 10.1007/s00261-024-04228-5. Epub 2024 Mar 8.
10
Clinical indications, safety, and effectiveness of percutaneous image-guided adrenal mass biopsy: an 8-year retrospective analysis in 160 patients.经皮影像引导下肾上腺肿块活检的临床指征、安全性和有效性:160 例患者 8 年回顾性分析。
Abdom Radiol (NY). 2024 Apr;49(4):1231-1240. doi: 10.1007/s00261-024-04211-0. Epub 2024 Mar 2.